Teva and IBM to expand global e-health alliance

Teva has announced that it will be expanding its global e-health alliance with IBM to encompass a number of new objectives.

The companies will be running projects to aid the discovery of new treatment options and improving chronic disease management using the IBM Watson Health Cloud platform.

A three-year research collaboration will be launched to develop cognitive technologies that can enable a systematic approach to the emerging field of drug repurposing, allowing new uses for existing drugs to be discovered on a larger scale than ever before.

Michael Hayden, Teva's president of global research and development and chief scientific officer, said: "This collaboration will bring together the science and the technology to scale up 'serendipity' to an industrial level, opening up new and exciting possibilities to create novel treatments for patients based on existing medicines."

It was also been confirmed that respiratory and central nervous system diseases will be the first targets for the companies' chronic disease management initiative, which will be the first project to integrate data from The Weather Company into the analysis.

The IBM Watson Health Cloud will be instrumental in this work, allowing researchers to gain individualised insights and a complete picture of the factors that affecting people's health.

With over 20 years of experience within the pharmaceutical market, we at Zenopa have the knowledge, skills and expertise to help find the right job for you. To find out more about the current pharmaceutical roles we have available, you can search for the latest job roles, register your details, or contact the team today.